// App-Quantinova.ai

14089 : Usefulness of N-Terminal Pro B-Type Natriuretic Peptide to Predict Survival in Patient with Low Flow, Low Gradient Aortic Stenosis with Reduced LV Ejection Fraction

Researchers

Presenter

  • Philippe Pibarot

Principal Investigators

  • Philipp Bartko

  • Gerald Mundigler

  • Ian Burwash

  • Abdellaziz Dahou

  • Helmut Baumgartner

  • Jean G Dumesnil

  • Jutta Bergler-Klein

Medical Centers

  • Ottawa Heart Inst, Ottawa, ON, Canada

  • Institut universitaire de cardiologie et de pneumologie de Quebec, Quebec, QC, Canada

  • Vienna General Hosp Univ, Vienna, Austria

  • University Hospital of Muenster, Muenster, Germany

Locations

  • Canada

  • Germany

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

Disease

  • Coronary Artery Disease

  • Chronic kidney disease

  • Aortic stenosis

  • Renal insufficiency

Biomarkers

  • B-type natriuretic peptide

  • N-terminal pro b-type natriuretic peptide

Drug/Treatment

  • Dobutamine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved